Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Rubius Therapeutics Inc (RUBY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Rubius Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.12 -0.49    -3.89%
12:23:52 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US78116T1034 
CUSIP:  78116T103
  • Volume: 119,504
  • Bid/Ask: 12.11 / 12.13
  • Day's Range: 12.06 - 12.54
Rubius Therapeutics 12.12 -0.49 -3.89%
Start Date Username Call Open Rate End Date Chg. %
Aug 27, 2021 Claudio Cortini   22.19 Sep 17, 2021 @ 20.89 -5.86%
Aug 12, 2021 Rainman Steinbrugger   24.49 Sep 03, 2021 @ 22.33 -8.82%
Apr 22, 2021 Robbert Kuipers   29.76 Apr 26, 2021 @ 24.30 -18.35%
Apr 01, 2021 Ian Smith   26.28 Apr 23, 2021 @ 24.66 -6.16%
Mar 26, 2021 Robbert Kuipers   25.70 Apr 16, 2021 @ 24.30 -5.45%
Mar 24, 2021 gabriel sosa   25.32 Apr 16, 2021 @ 24.30 -4.03%
Mar 23, 2021 julio HERRERA   24.03 Apr 16, 2021 @ 24.30 +1.12%
Mar 23, 2021 julio HERRERA   24.03 Apr 16, 2021 @ 24.30 +1.12%
Mar 22, 2021 Mohammad Syahril...   25.18 Apr 16, 2021 @ 24.30 -3.49%
Mar 17, 2021 Piero Santoro   24.74 Mar 18, 2021 @ 24.51 +0.93%
Mar 17, 2021 julio HERRERA   26.10 Mar 23, 2021 @ 24.55 -5.94%
Mar 16, 2021 Ivan Lopez   31.96 Apr 09, 2021 @ 23.88 -25.28%
Mar 16, 2021 Jose Roberto   34.68 Apr 09, 2021 @ 23.88 +31.14%
Mar 15, 2021 Ido Rosenfeld   31.00 Apr 09, 2021 @ 23.88 +22.97%
Mar 15, 2021 James Buremoh   31.39 Apr 09, 2021 @ 23.88 -23.92%
Mar 15, 2021 יוסי אסייג   32.10 Apr 09, 2021 @ 23.88 +25.61%
Mar 15, 2021 Berkay ÇETİN   29.61 Mar 22, 2021 @ 25.32 -14.49%
Mar 15, 2021 Sez Yi   29.94 Mar 15, 2021 @ 30.38 +1.47%
Mar 15, 2021 Slava Babaev   27.14 Apr 09, 2021 @ 23.88 +12.01%
Mar 15, 2021 Marina Pardo Carvajal   25.25 Apr 09, 2021 @ 23.88 -5.43%
Mar 15, 2021 Robert Wagner   29.61 Apr 09, 2021 @ 23.88 -19.35%
Mar 15, 2021 Netanel Cohen   30.81 Apr 09, 2021 @ 23.88 -22.49%
Mar 15, 2021 bruno casella   35.50 Apr 09, 2021 @ 23.88 -32.73%
Mar 15, 2021 András Cruder   36.35 Mar 15, 2021 @ 26.50 +27.10%
Mar 12, 2021 sushil maslekar   16.91 Apr 02, 2021 @ 25.00 +47.84%
Mar 09, 2021 שי אטיאס   14.95 Apr 02, 2021 @ 25.00 +67.22%
Mar 05, 2021 רונן בן חמו   14.08 Mar 26, 2021 @ 24.62 +74.86%
Mar 05, 2021 Piero Santoro   13.99 Mar 05, 2021 @ 13.42 +4.07%
Feb 26, 2021 Emrah Cengiz   10.20 Mar 19, 2021 @ 25.31 +148.14%
Jan 27, 2021 Uriel Navarro   14.39 Feb 19, 2021 @ 12.64 -12.16%
Dec 15, 2020 Ben Rickert   7.49 Jan 05, 2021 @ 8.35 +11.48%
Dec 15, 2020 Mark whitehouse   7.36 Jan 08, 2021 @ 9.53 +29.48%
Dec 15, 2020 Carlos Volquez   7.05 Jan 08, 2021 @ 9.53 +35.18%
Dec 15, 2020 Gabriel Gamboa   7.14 Jan 08, 2021 @ 9.53 +33.47%
Dec 15, 2020 Talal Shamma   7.25 Jan 08, 2021 @ 9.53 +31.45%
Dec 14, 2020 Jim Pletsas   9.46 Jan 08, 2021 @ 9.53 +0.74%
Dec 14, 2020 성조 황   9.60 Jan 08, 2021 @ 9.53 -0.73%
Dec 14, 2020 Mor Fink   9.74 Dec 14, 2020 @ 10.34 +6.16%
Dec 14, 2020 영석 조   9.74 Jan 08, 2021 @ 9.53 -2.16%
Dec 14, 2020 Sladgen Yerkovic   12.62 Jan 08, 2021 @ 9.53 +24.48%
Dec 14, 2020 Timo Saari   12.20 Jan 08, 2021 @ 9.53 +21.89%
Sep 10, 2020 Aurimas Miskinis   5.07 Oct 02, 2020 @ 4.72 +6.90%
May 20, 2020 Kenan Yasar   6.12 Jun 12, 2020 @ 6.06 -0.98%
May 07, 2020 Антон Туманов   5.96 May 29, 2020 @ 6.45 -8.22%
Apr 16, 2020 SS SS   4.77 May 08, 2020 @ 6.22 +30.40%
Apr 16, 2020 shahrul nizam   4.86 May 08, 2020 @ 6.22 +27.98%
Mar 12, 2020 Andreas Schatz   3.53 Apr 03, 2020 @ 4.35 +23.23%
Dec 19, 2019 宏 王   11.56 Jan 10, 2020 @ 9.34 +19.20%
Dec 19, 2019 sas stas   11.54 Jan 10, 2020 @ 9.34 +19.06%
Dec 18, 2019 Gabriel Gamboa   13.95 Jan 10, 2020 @ 9.34 -33.05%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RUBY Comments

Write your thoughts about Rubius Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alex Kosh
Alex Kosh Apr 01, 2021 4:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it gonna be EntreMed number 2?
Frank Marone
Frank Marone Mar 16, 2021 7:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Looking for additional insights into their pipelina?
Frank Marone
Frank Marone Mar 16, 2021 7:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ruby has anazing technolgy in approaching Cancer with a grear Board and officers. Could be a big winner
Paul Barron
Paul Barron Mar 16, 2021 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Remember seeing Silver companies. HL, MAG, AG SVM, FVI, in short order you will need this information. Keep a copy of this.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email